Viemed Healthcare (VMD) Shares Outstanding (Weighted Average) (2018 - 2026)

Viemed Healthcare has reported Shares Outstanding (Weighted Average) for 9 years, with the latest figure at $38.4 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) fell 2.53% year-over-year to $38.4 million; the trailing twelve-month figure through Mar 2026 stood at $38.4 million (down 2.53% YoY), and the FY2025 full-year result was $38.9 million, changed 0.36% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $38.4 million, down from $38.9 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $39.6 million in Q1 2022, with the low at $38.2 million in Q1 2023.
• Historically, Shares Outstanding (Weighted Average) has averaged $38.7 million across 5 years, with a median of $38.7 million in 2022.
• Annual changes were most pronounced in 2023 — Shares Outstanding (Weighted Average) retreated 3.7% — and 2025, when it increased 2.48%.
• Viemed Healthcare's Shares Outstanding (Weighted Average) stood at $38.7 million in 2022, then declined by 0.78% to $38.4 million in 2023, then advanced by 1.05% to $38.8 million in 2024, then grew by 0.36% to $38.9 million in 2025, then retreated by 1.2% to $38.4 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $38.4 million (Q1 2026), $38.9 million (Q4 2025), and $38.6 million (Q3 2025), per Business Quant data.